Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “PLACENTAL HORMONES”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 487 records · Page 27Linked to original sources
PubMed1976

Prognostic value of antenatal screening.

Rates of stillbirths and first-week deaths have fallen steadily in Scotland in the last 30 years. Seventy-five per cent of all such deaths in the City of Dundee now follow the clinical condition of "antepartum hemorrhage," "premature labor," "poor fetal growth," and "lethal deformity," all of which are conditions associated with poorer environmental conditions which are worse in larger industrial cities. Therefore, we are concerned with these clinical situations and with fetal death and subsequent morbidity of children born in those situations. This paper describes in summary a planned study of antenatal screening with assessment of fetal placental hormones, fetal biparietal diameter, and other determinants of fetal well-being, the growth of the child and weight at birth, the quality of the labor, the neonatal state, and the ultimate quality of the child.

Amniotic Fluid↗
PubMed1978

Studies with a pancreatic beta cell simulator in the third trimester of pregnancies complicated by diabetes.

To determine the potential of an artificial pancreatic beta cell simulator as a therapeutic and research tool we have used the device for short-term monitoring and control of blood glucose concentrations in five pregnant patients with juvenile-onset diabetes (White's Class C) and three pregnant patients with maturity-onset diabetes (Class B). One patient with brittle juvenile-onset diabetes had successful control before, during, and after cesarean section. The other seven patients were studied during the third trimester of pregnancy and at least four weeks before delivery. Blood glucose control with Biostator regulation was excellent (mean, 96 mg. per deciliter; range, 85 to 107). The insulin requirements needed to achieve optimal glucose control with the Biostator were highly variable (range, 20 to 157 U. per 24 hours) but very similar to those previously calculated to provide optimal control by conventional means. Insulin requirements were unrelated to plasma growth hormone, placental lactogen, or glucagon concentrations. The greatest degree of insulin resistance was seen in obese patients with endogenous insulin-secretory capacity. This study indicates that a pancreatic beta cell simulator can normalize glucose concentrations and rapidly estimate daily insulin requirements in pregnant diabetic patients. In addition, the data suggest that exogenous insulin may indirectly suppress endogenous insulin secretion and thus contribute to the "insulin resistance" of obese patients with maturity-onset diabetes.

Adult↗
PubMed1993

Fetal nutrition and cardiovascular disease in adult life.

Babies who are small at birth or during infancy have increased rates of cardiovascular disease and non-insulin-dependent diabetes as adults. Some of these babies have low birthweights, some are small in relation to the size of their placentas, some are thin at birth, and some are short at birth and fail to gain weight in infancy. This paper shows how fetal undernutrition at different stages of gestation can be linked to these patterns of early growth. The fetuses' adaptations to undernutrition are associated with changes in the concentrations of fetal and placental hormones. Persisting changes in the levels of hormone secretion, and in the sensitivity of tissues to them, may link fetal undernutrition with abnormal structure, function, and disease in adult life.

Adult↗
PubMed1994

Adhesion and invasion of three human choriocarcinoma cell lines into human endometrium in a three-dimensional organ culture system.

A novel in vitro model was developed to study attachment and invasion of choriocarcinoma cell spheroids using pre-cultured secretory phase human endometrium as a host tissue. During pre-culturing in shaker culture human endometrium had regenerated a complete epithelial covering and had shed cells damaged during explantation. Spheroids of three human choriocarcinoma cell lines (BeWo, Jeg-3, JAr) which displayed linear growth in culture and produced placental hormones were used in this study as models for trophoblast behaviour. Morphological differences were noted in the spheroids from the three choriocarcinoma cell lines; BeWo and Jeg-3 spheroids exposed flattened and more differentiated cells on their surfaces while superficial cells in JAr spheroids maintained their cytotrophoblast-like morphology. Spheroids from all three cell lines were proven to be invasive in a general invasion assay using embryonic chick heart fragments, with JAr spheroids being the most aggressive. When spheroids were confronted with pre-cultured re-epithelialized endometrial fragments, however, Jeg-3 spheroids showed the highest incidence of attachment (52%) and the greatest amount of invasion into the underlying stroma. BeWo spheroids also attached (37%) and penetrated the epithelium, but did not invade into the stroma. JAr spheroids showed a minor degree of attachment (12%) and little or no invasion into the stroma. These results show that the three choriocarcinoma cell lines, although all invasive in a general invasion assay, differ in adhesion to uterine epithelium and invasion into endometrial stroma. This model offers opportunities for studying mechanisms of trophoblast adhesion and invasion, using human endometrium as the natural host tissue.

Animals↗
PubMedDate not supplied

Feto-maternal interaction of IGF-I and its binding proteins in fetal growth.

Elevated levels of maternal IGF-I and IGF-binding proteins IGFBP-1 are regulated by placental hormones rather than pituitary control during pregnancy. Maternal IGF-I promotes fetal growth by stimulating nutrient transfer to fetus through placenta and IGFBP-1 suppresses fetal growth by inhibiting IGF-I binding to receptors in placenta. Since IGF-I and IGFBP-1 are produced in placenta and decidua, respectively, fetal growth is regulated by these substances in the locally formed paracrine system.

Carrier Proteins↗
PubMed2006

Use of oral decongestants during pregnancy and delivery outcome.

OBJECTIVE: The purpose of this study was to evaluate delivery outcome after maternal use of oral decongestants. STUDY DESIGN: We identified 2474 women who had reported the use of oral decongestants (mainly phenylpropanolamine) during early pregnancy and 1771 women who used prescription oral decongestants later in pregnancy. With Mantel-Haenszel analysis, comparisons were made with all women who gave birth in Sweden. RESULTS: The risk ratio for any congenital malformation after the use of oral decongestants was 0.96 (95% CI, 0.80-1.16). Women who were prescribed decongestants after the first antenatal visit less often than expected had infants who were born preterm (odds ratio, 0.68; 95% CI, 0.52-0.88), of low birth weight (odds ratio, 0.53; 95% CI, 0.37-0.77), small-for-date (odds ratio, 0.71; 95% CI, 0.47-1.08), or perinatally dead (odds ratio, 0.53; 95% CI, 0.22-12.5). CONCLUSION: No teratogenic effect of oral decongestants was found. An association found between the late pregnancy use of such drugs and a favorable neonatal outcome can be explained hypothetically by the postulated association between pregnancy rhinitis and placental hormones.

Administration, Oral↗
PubMed1996

The effect of ovulation induction on the concentration of maternal serum relaxin in twin pregnancies.

OBJECTIVE: Our purpose was to determine the effects of fetal number, various ovulation induction treatments, and placental hormones on the concentration of maternal serum relaxin. STUDY DESIGN: The concentrations of relaxin, human chorionic gonadotropin, estriol, and alpha-fetoprotein were determined in blood samples drawn at 16 to 18 weeks for prenatal diagnosis in 72 singleton and 115 twin pregnancies and analyzed by one-way analysis of variance, correlation analysis, and stepwise multiple linear regression of the log-transformed data. RESULTS: The maternal serum concentrations of each of the four measured hormones were significantly higher in the twin pregnancies than in the singleton pregnancies: 1.4-fold for relaxin, 1.9-fold for human chorionic gonadotropin, 1.9-fold for estriol, and 2.2-fold for alpha-fetoprotein (all p < 0.01). The concentrations of each of the four hormones were significantly correlated with each of the others and with the number of fetuses (p < 0.01), except that estriol was not significantly correlated with human chorionic gonadotropin. The serum relaxin concentration in twin pregnancies after treatment with follicle-stimulating hormone and luteinizing hormone (menotropins) (n = 10) was 3.3-fold that in twins resulting from spontaneous ovulation (n = 89, p < 0.01). In twins resulting from in vitro fertilization or gamete intrafallopian transfer (n = 9) the serum relaxin concentration was 2.6-fold higher than in twins resulting from spontaneous ovulation (p < 0.01). The effect of clomiphene citrate (1.2-fold, n = 7) failed to reach statistical significance. CONCLUSIONS: The second fetus causes a 1.4-fold increase in the concentration of maternal serum relaxin in twin pregnancies. Induction of ovulation with menotropins causes an additional 3.3-fold increase, whereas in vitro fertilization or gamete intrafallopian transfer treatment causes an additional 2.6-fold increase over that seen in twin pregnancies that followed spontaneous ovulation.

Chorionic Gonadotropin↗